• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume10, Issue2

Appraisal of rabies immunoglobulin among the animal bite cases

    Mamata Rani Giri, Tripathy Abinash, Kar Krishna

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 2, Pages 1056-1059

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Rabies is widely prevalent in India. Estimated annual death in India due to rabies is 20000. Prompt and adequate treatment of animal bite is of utmost important in the prevention of rabies. Wound infiltration with RIG in Cat-III animal bite cases is to neutralize the virus at the wound site. It is to be infiltrate thoroughly in all sides of the wound with minimum tissue damage. With this background the present study was conducted with the following objectives.
Objectives

To assess the proper method of administration of RIG in Cat-III animal bite cases.
To assess the time lag between bite bite and RIG administration.
To assess the availability, accessibility, acceptability and adverse effect of RIG among patients.

Study Design: Cross-sectional study.
Place of study: ARV Clinic of PRM Medical College & Hospital, Baripada, Mayurbhanj, Odisha.
Study Subjects: All new cases of Cat-III animal bite attending the ARV Clinic during the study period.
Study Period: September 2022 to November 2022.
Study Instrument: A per-designed pretested questionnaires.
Data analysis: It was analyzed with MS Excel.
Result: A total of 281 Cat-III new animal bite cases were participated, out of them 55(19.57%) were belong to pediatric age group (<14 year) and 226(80.43%) study subjects were more than 14 years. Regarding the reporting time to the health facility after animal bite, most of the cases 253(90.04%) reported to the ARV Clinic within 24 hrs & less numbers 28(9.96%) reported more than 48 hrs. All the Cat-III bites had given anti rabies vaccination along with Rabies Immunoglobulin. Out of 281 study subjects Paediatrics age group 55(19.57%) were administered human rabies immunoglobulin (HRIG) & 226(80.43%) administered equine rabies immunoglobulin (ERIG). In all the cases RIG was administered as per the WHO recommendation with respect to dose & method of administration. ERIG was administered after doing skin sensitive test. There were no side effects among the study subjects after RIG administration. All the Cat-III bites had given the vaccine and RIG for the animal bite management on the day of their visit to the ARV clinic. During the study period both HRIG & ERIG were available in the ARV clinic which was free of cost for the patients. No side effects were reported among the study subjects after RIG administration
Keywords:
    Rabies category-iii rabies immunoglobulin animal bite
  • PDF (121 K)
  • XML
(2023). Appraisal of rabies immunoglobulin among the animal bite cases. European Journal of Molecular & Clinical Medicine, 10(2), 1056-1059.
Mamata Rani Giri, Tripathy Abinash, Kar Krishna. "Appraisal of rabies immunoglobulin among the animal bite cases". European Journal of Molecular & Clinical Medicine, 10, 2, 2023, 1056-1059.
(2023). 'Appraisal of rabies immunoglobulin among the animal bite cases', European Journal of Molecular & Clinical Medicine, 10(2), pp. 1056-1059.
Appraisal of rabies immunoglobulin among the animal bite cases. European Journal of Molecular & Clinical Medicine, 2023; 10(2): 1056-1059.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 13
  • PDF Download: 59
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus